Rockville, M.D., and Charlotte, N.C., April 12, 2023 – ExeGi Pharma LLC (“ExeGi”), a leading developer of live biotherapeutic drugs and probiotics, has announced a partnership with TannerLAC, Inc. (“TannerLAC”), a division of Tanner Pharma Group, to distribute Visbiome in Mexico.

Visbiome is a high potency probiotic medical food designed to manage microbial imbalances associated with medical conditions such as irritable bowel syndrome (IBS), Ulcerative Colitis (UC), Antibiotic-Associated Diarrhea (AAD), Pouchitis, and Hepatic Encephalopathy (HE). With a proven track record in over 80 human clinical trials performed over the past 20 years, Visbiome is the most extensively researched multi-strain probiotic available.

TannerLAC provides pharmaceutical, biotech, and healthcare companies with a single-point partner for the commercialization of their products in challenging international markets. Under the license agreement, Tanner will register, commercialize, and promote Visbiome initially in Mexico, with plans to expand to other Latin American countries.

“We are excited to collaborate with Tanner to make Visbiome® accessible to patients in Mexico,” said Marc Tewey, ExeGi’s CEO. “The Tanner team is ideally suited to manage the regulatory and commercial requirements for distributing our product to our Mexican neighbors.”

“Years ago, I witnessed firsthand how Visbiome transformed the lives of two people close to me,” said Carolina Cortez, EVP of TannerLAC. “Today, we are thrilled to partner with ExeGi and begin our journey in Mexico. We are confident that Visbiome® will be a valuable addition to our portfolio and will enable patients in Mexico to finally access this potent probiotic that has proven to support individuals with various digestive conditions.”

To learn more about Visbiome, please visit www.visbiome.com.

About ExeGi Pharma

ExeGi Pharma LLC is a biotechnology company focused on developing and commercializing live biotherapeutic and probiotic medicines. Our purpose is to formulate the most effective probiotics and live biotherapeutics to provide relief from serious conditions so people, and their pets, may live healthier lives. ExeGi is headquartered in Rockville, MD. For more information, please visit www.exegipharma.com.

About Tanner Pharma Group Tanner Pharma Group is a specialist pharmaceutical partner focused on improving global access to medicines. By partnering with Tanner Pharma, companies can focus on their primary markets while ensuring that patients and clinicians in international markets can also benefit from using their products. Tanner Pharma has a global reach and provides international commercialization and patient access through product registration and licensing, managed and global access programs and clinical trial solutions. For more information, please visit www.tannerpharma.com.